20-46120612-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001250.6(CD40):​c.52-1208T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.745 in 152,240 control chromosomes in the GnomAD database, including 42,597 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.75 ( 42597 hom., cov: 34)

Consequence

CD40
NM_001250.6 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.233

Publications

67 publications found
Variant links:
Genes affected
CD40 (HGNC:11919): (CD40 molecule) This gene is a member of the TNF-receptor superfamily. The encoded protein is a receptor on antigen-presenting cells of the immune system and is essential for mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development, and germinal center formation. AT-hook transcription factor AKNA is reported to coordinately regulate the expression of this receptor and its ligand, which may be important for homotypic cell interactions. Adaptor protein TNFR2 interacts with this receptor and serves as a mediator of the signal transduction. The interaction of this receptor and its ligand is found to be necessary for amyloid-beta-induced microglial activation, and thus is thought to be an early event in Alzheimer disease pathogenesis. Mutations affecting this gene are the cause of autosomal recessive hyper-IgM immunodeficiency type 3 (HIGM3). Multiple alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Nov 2014]
CD40 Gene-Disease associations (from GenCC):
  • hyper-IgM syndrome type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001250.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.83 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001250.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD40
NM_001250.6
MANE Select
c.52-1208T>C
intron
N/ANP_001241.1P25942-1
CD40
NM_001322421.2
c.52-1208T>C
intron
N/ANP_001309350.1
CD40
NM_001302753.2
c.52-1208T>C
intron
N/ANP_001289682.1A0A8Q3SI60

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD40
ENST00000372285.8
TSL:1 MANE Select
c.52-1208T>C
intron
N/AENSP00000361359.3P25942-1
CD40
ENST00000372276.7
TSL:1
c.52-1208T>C
intron
N/AENSP00000361350.3P25942-2
CD40
ENST00000466205.5
TSL:1
n.46-1208T>C
intron
N/AENSP00000434825.1H0YE23

Frequencies

GnomAD3 genomes
AF:
0.745
AC:
113331
AN:
152122
Hom.:
42551
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.838
Gnomad AMI
AF:
0.751
Gnomad AMR
AF:
0.748
Gnomad ASJ
AF:
0.649
Gnomad EAS
AF:
0.568
Gnomad SAS
AF:
0.730
Gnomad FIN
AF:
0.698
Gnomad MID
AF:
0.709
Gnomad NFE
AF:
0.716
Gnomad OTH
AF:
0.722
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.745
AC:
113434
AN:
152240
Hom.:
42597
Cov.:
34
AF XY:
0.740
AC XY:
55054
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.837
AC:
34769
AN:
41522
American (AMR)
AF:
0.749
AC:
11454
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.649
AC:
2252
AN:
3472
East Asian (EAS)
AF:
0.568
AC:
2941
AN:
5178
South Asian (SAS)
AF:
0.729
AC:
3521
AN:
4828
European-Finnish (FIN)
AF:
0.698
AC:
7393
AN:
10594
Middle Eastern (MID)
AF:
0.707
AC:
208
AN:
294
European-Non Finnish (NFE)
AF:
0.716
AC:
48679
AN:
68022
Other (OTH)
AF:
0.724
AC:
1532
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1498
2997
4495
5994
7492
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
850
1700
2550
3400
4250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.727
Hom.:
77330
Bravo
AF:
0.753
Asia WGS
AF:
0.712
AC:
2475
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
8.7
DANN
Benign
0.88
PhyloP100
0.23
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4239702;
hg19: chr20-44749251;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.